It is created for in vitro quantitative detection of the concentration of C-reactive (CRP) and hypersensitive CRP (hsCRP) proteins in human serum, plasma, and whole blood samples. Automated and objective results in 3 minutes by immunofluorescent assay.
– Assistant means of cardiovascular disease risk identification
– Extensive results by printer
– Reconnect of previous results
– Android based interface
– Reliable
– Breakneck results
– Test Cassette
– Sample Diluent
– Pipette Tip
– ID Chip
– Instruction for Use
Intended use | Detection of SARS-CoV-2 antigen |
---|---|
Storage | 2-30℃ / 35.6-86℉ |
Specimen type | Nasal swab |
Time to result | 15-30 minutes |
Shelf life | 24 months |
Sensitivity | 93.1% |
Specificity | 100.0% |
.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }
Ref. No. |
Target |
Specimen |
Kit Size |
Certification |
---|---|---|---|---|
VMPO11 |
C-reactive (CRP) and hypersensitive CRP (hsCRP) Proteins |
S/P/WB |
25 T |
S: Serum, P: Plasma, WB: Whole Blood